Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118325955 | 11832595 | 5 | F | 201511 | 20160725 | 20151214 | 20160802 | EXP | CA-PFIZER INC-2015438353 | PFIZER | 65.00 | YR | F | Y | 0.00000 | 20160802 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118325955 | 11832595 | 1 | SS | ENBREL | ETANERCEPT | 1 | UNK | Y | 0 | ||||||||||
| 118325955 | 11832595 | 2 | PS | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | Y | 7073 | ||||||||||
| 118325955 | 11832595 | 3 | SS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | UNK | U | 20607 | TABLET | |||||||||
| 118325955 | 11832595 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | 11719 | |||||||||||
| 118325955 | 11832595 | 5 | SS | CELEBREX | CELECOXIB | 1 | UNK | 20998 | CAPSULE, HARD | ||||||||||
| 118325955 | 11832595 | 6 | SS | ARAVA | LEFLUNOMIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 118325955 | 11832595 | 7 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118325955 | 11832595 | 1 | Rheumatoid arthritis |
| 118325955 | 11832595 | 2 | Rheumatoid arthritis |
| 118325955 | 11832595 | 3 | Rheumatoid arthritis |
| 118325955 | 11832595 | 4 | Rheumatoid arthritis |
| 118325955 | 11832595 | 5 | Rheumatoid arthritis |
| 118325955 | 11832595 | 6 | Rheumatoid arthritis |
| 118325955 | 11832595 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118325955 | 11832595 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118325955 | 11832595 | Blood test abnormal | |
| 118325955 | 11832595 | Condition aggravated | |
| 118325955 | 11832595 | Drug effect decreased | |
| 118325955 | 11832595 | Drug hypersensitivity | |
| 118325955 | 11832595 | Joint destruction | |
| 118325955 | 11832595 | Joint range of motion decreased | |
| 118325955 | 11832595 | Joint swelling | |
| 118325955 | 11832595 | Pain | |
| 118325955 | 11832595 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118325955 | 11832595 | 1 | 2013 | 201511 | 0 |